Tang Capital Management as of March 31, 2013
Portfolio Holdings for Tang Capital Management
Tang Capital Management holds 24 positions in its portfolio as reported in the March 2013 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Pdl Biopharma Inc cnv | 15.8 | $48M | 38M | 1.29 | |
| Mannkind Corp note 3.750%12/1 | 12.1 | $37M | 42M | 0.89 | |
| Pcrx 3 1/4 02/01/19 144a | 10.5 | $32M | 24M | 1.37 | |
| Opko Health Inc note 3.0% 2/1/33 | 10.5 | $32M | 30M | 1.09 | |
| Dendreon Corp note | 6.8 | $21M | 27M | 0.78 | |
| DepoMed | 5.2 | $16M | 2.7M | 5.87 | |
| Salix Pharmaceuticals | 5.0 | $15M | 300k | 51.18 | |
| Intermune Inc note 2.500% 9/1 | 4.7 | $14M | 17M | 0.84 | |
| Nektar Therapeutics (NKTR) | 3.8 | $12M | 1.0M | 11.00 | |
| BioMarin Pharmaceutical (BMRN) | 3.7 | $11M | 181k | 62.26 | |
| Ironwood Pharmaceuticals (IRWD) | 3.6 | $11M | 600k | 18.28 | |
| OncoGenex Pharmaceuticals | 3.5 | $11M | 933k | 11.33 | |
| Savient Pharmaceuticals note | 2.7 | $8.2M | 31M | 0.27 | |
| Vanda Pharmaceuticals (VNDA) | 2.2 | $6.9M | 1.8M | 3.92 | |
| Endocyte | 1.9 | $5.8M | 466k | 12.45 | |
| MannKind Corporation | 1.8 | $5.6M | 1.7M | 3.39 | |
| Cyclacel Pharmaceuticals | 1.4 | $4.3M | 765k | 5.59 | |
| Arena Pharmaceuticals | 1.3 | $3.9M | 478k | 8.21 | |
| Anthera Pharmaceuticals | 1.1 | $3.5M | 5.3M | 0.66 | |
| Neoprobe | 0.9 | $2.6M | 968k | 2.71 | |
| Oncothyreon | 0.7 | $2.0M | 985k | 2.08 | |
| Questcor Pharmaceuticals | 0.5 | $1.6M | 50k | 32.54 | |
| Affymax (AFFY) | 0.2 | $721k | 526k | 1.37 | |
| Dendreon Corporation | 0.1 | $377k | 80k | 4.74 |
